Bristol-Myers Squibb
- Market cap
- 125.71B
- P/E (TTM)i
- 13.56
- P/Bi
- 5.63
- EPSi
- 3.46
- Div yieldi
- 4.08%
- 52W posi
- 74%
Anonymous reader poll. Unscientific, not investment advice.
Bristol-Myers Squibb ended the session at 61.54, down 1.14%. The company carries a market value of roughly 125.71B, the #122 most valuable US-listed company we track. Valuation-wise, the P/E sits at 14.01, 59% above the five-year average of 8.81. It pays a dividend yielding 4.08% on a trailing basis. Wall Street's 18-analyst consensus lands on Buy, with a price target averaging 67.88 (+10% from here). Against a 52-week band of 41.13-68.64, the shares are currently 74% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 29% of the universe, above its 200-day average.
- Signal has read BUY for 7 days.
- Recent price momentum is +28.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 2.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 299 U.S. stocks StockVane covers.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 13.6x | Better than 84% |
| Forward P/E | 16.0x | Better than 66% |
| Price / Sales | 2.6x | Better than 71% |
| P/E vs own 5-yr range | 38th pctl | Better than 73% |
Growth C-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 1.4% | Better than 22% |
| Net income CAGR (3Y) | 3.7% | Better than 38% |
| Free cash flow CAGR (3Y) | 2.4% | Better than 36% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 71.1% | Better than 82% |
| Operating margin | 28.5% | Better than 68% |
| Net margin | 14.6% | Better than 43% |
| Return on equity | 40.5% | Better than 79% |
| Return on invested capital | 12.7% | Better than 51% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 13.9% | Better than 76% |
| 6-month return | 7.4% | Better than 45% |
| 12-month return (ex latest month) | 57.0% | Better than 81% |
| Distance below 52-week high | 10.0% | Better than 62% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.3x | Better than 51% |
| Debt to assets | 255.2% | Better than 10% |
| Interest coverage | 5.9x | Better than 31% |
| Free cash flow / net income | 182.1% | Better than 86% |
Analyst View D+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 44.4% | Better than 13% |
| Upside to average target | 9.9% | Better than 22% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 62.25
- Open
- 62.36
- Day range
- 61.45 - 62.65
- Avg price
- 61.79
- Volume
- 4.59M
- Turnover
- 283.33M
- Turnover ratei
- 0.23%
- Volume ratioi
- 0.38
- Amplitudei
- 1.93%
- 52-week rangei
- 41.13 - 68.64
Valuation
- P/Ei
- 17.79
- P/E (TTM)i
- 13.56
- P/Bi
- 5.63
- EPSi
- 3.46
- Book value / shi
- 10.93
- Net profit
- 7.07B
- Net assets
- 22.32B
Share structure
- Market cap
- 125.71B
- Float capi
- 125.51B
- Shares out
- 2.04B
- Float sharesi
- 2.04B
Dividend & listing
- Div yield (TTM)i
- 4.08%
- Dividend (TTM)
- 2.51
- Listing date
- 1970-01-01
10.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-81.67M net over the window
Short interest
- Shares short
- 44.07M
- % of floati
- 2.16%
- Days to coveri
- 5.27
- As of
- 2026-08-31
Frequently asked questions
What is the current stock price of Bristol-Myers Squibb (BMY)?
Bristol-Myers Squibb last traded at 61.54. The quote on this page refreshes every few seconds while US markets are open.
What is Bristol-Myers Squibb's market cap?
About 125.71B.
What is the P/E ratio of Bristol-Myers Squibb?
The trailing twelve-month P/E is 13.56, above its own 5-year average of 8.81 — in the middle of its historical range (37.56% percentile). See the Valuation tab for the full history.
Does Bristol-Myers Squibb pay a dividend?
Yes. The trailing dividend yield is 4.08%. See the Dividends tab for the full payment history.
Is Bristol-Myers Squibb a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 67.88, which implies 10.3% upside from the current price. This is not investment advice.
Quote time 2026-09-23 14:20:00 · For reference only, not investment advice.